Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Removes Ulta Salon (ULTA) from their Alpha List
-
Piper Jaffray Downgrades RC2 Corporation (RCRC) to Hold
-
Piper Jaffray Downgrades AnnTaylor Stores (ANN) to Sell
-
Unusual 11 Mid-Day Movers 8/12: USS, APII, CMLS, LDK Higher; ALTU, SCA, SIL, COMV Lower
-
Piper Jaffray Downgrades Sonus Networks (SONS) to Neutral
-
Piper Jaffray Upgrades LDK Solar (LDK) to Neutral Following Strong Results
-
Piper Jaffray Downgrades MannKind (MNKD) to Sell
-
Piper Jaffray Maintains 'Buy' Rating on Physicians Formula Holdings (FACE), But Lowers PT and Estimates
-
Notable Analyst Rating Changes 8/12: FCX, PVA, RIO, DAL, CAL, AMR Upgraded; GS, WYNN, LUV, MCD Downgraded
-
Piper Jaffray Downgrades American Oriental Bioengineering (AOB) to Neutral
-
Piper Jaffray Downgrades Houston Wire & Cable (HWCC) to Neutral
-
Piper Jaffray Initiates United Therapeutics (UTRH) with a Sell
-
Piper Jaffray Resumes Metabasis Therapeutics (MBRX) with a Buy
-
Piper Jaffray Initiates Cyclacel Pharmaceuticals (CYCC) with a Buy
-
Piper Jaffray Assumes Allos Therapeutics (ALTH) with a Buy
-
Piper Jaffray Initiates Inspire Pharmaceuticals (ISPH) with a Buy
-
Piper Jaffray Initiates Aradigm Corporation (ARDM) with a Buy
-
Piper Jaffray Initiates Sunesis Pharmaceuticals (SNSS) with a Buy
-
Piper Jaffray Initiates Hana Biosciences (HNAB) with a Buy
-
Piper Jaffray Increases Their Price Target on Beacon Roofing Supply (BECN) to $18; Removes from Alpha List
-
Deckers (DECK): Colour on quarter
-
Piper Jaffray Downgrades 3D Systems (TDSC) to Sell
-
Notable Analyst Rating Changes 8/7: S, RIG, FTI, HAYN Upgraded; AIG, FRE, CTRN, BBT Downgraded
-
Piper Jaffray Downgrades Citi Trends (CTRN) to Neutral
-
Piper Jaffray Downgrades CastlePoint Holdings (CPHL) to Neutral
-
Piper Jaffray Downgrades Hot Topic (HOTT) to Neutral
-
Piper Jaffray Downgrades Jamba Inc. (JMBA) to Sell
-
Piper Jaffray Downgrades Anaren (ANEN) to Neutral
-
Piper Jaffray Reiterates $45 Price Target on Yingli (YGE)
-
Piper Jaffray Lowers Their Price Target on Cisco Systems (CSCO) to $29; Reiterates Buy
-
Piper Jaffray Downgrades ACADIA Pharma (ACAD) to Neutral
-
Piper Jaffray Says Now Is A Perfect Time To Pick Up EnergySolutions (ES)
-
Biogen Idec (BIIB) Sinks on TYSABRI PML Fears, Wall Street Comments...
-
Piper Jaffray Raises Price Target on Activision Blizzard (ATVID) to $40
-
Notable Analyst Rating Changes 8/1: AKAM, MOT, CVC Upgraded; NMX, SPF, MNST Downgraded
-
Piper Jaffray Downgrades TomoTherapy (TOMO) to Neutral; Removes from Alpha List
-
Piper Jaffray Upgrades Motorola (MOT) to Neutral
-
Piper Jaffray Downgrades Shutterfly (SFLY) to Neutral
-
Piper Jaffray Reduces Their Price Target on THQ Inc. (THQI) to $17; Reiterates Neutral
-
Piper Jaffray Lowers Their Price Target on Akamai Technologies (AKAM) to $35; Maintains Buy
-
Piper Jaffray Downgrades Bare Escentuals (BARE) to Neutral; Removes From Alpha List
-
Elan (ELN): Bounce?
-
Piper Jaffray Upgrades WuXi PharmaTech (WX) to Buy
-
China Distance Education Holdings (DL) Lowers IPO Price Range to $7-$8
-
Piper Jaffray Initiates American Physicians Service (AMPH) with a Buy
-
Piper Jaffray Initiates American Physicians Capital (ACAP) with a Neutral
-
Piper Jaffray Initiates ProAssurance Corp. (PRA) with a Buy
-
Piper Jaffray Downgrades Entropic Communications (ENTR) to Neutral
-
Notable Analyst Rating Changes 7/25: DAL, GOOG, CSIQ, JNPR Upgraded; SIRI, SSP, ANF Downgraded
-
David Moenning's Daily State of the Markets: 7/25
